Study title: An open, not-controlled study to assess the safety and efficacy of oxymetazoline 0.01 % in infants suffering from rhinitisPlease see report
Type of medicine: Medicines containing chemical active substances | |||||
Therapeutic area: | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report, Please see report | |||||
Assessment: | |||||
Active substance: OXYMETAZOLINE | |||||
ATC code: R01A A05 | |||||
Document link: 6529-660-59-190375 - Nasivin 0.01% (Oxymetazoline hydrochloride) - Semmelmayer 1972 - EUdraCT_reduced datafields for Interim publication.xls | |||||
Document date: 2015-02-19 | |||||
Study number: | |||||
EudraCT number: | |||||
Scope of study: Clinical | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | Y | Y | - | - |